StockData
Merck & Co., Inc. logo

Merck & Co., Inc. (MRK) operating KPIs

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)

Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%

Merck u.S. Chargebacks & Rebates Accrual — Current-Year Sales Provision ($M) ($M)

Form 10-K Critical Accounting Estimates

Latest, FY2025
10,219
Period ended Dec 31, 2025
Change on a year earlier
-24.0%
13,450 in FY2024
History
10 years
Since FY2016
Sources
9
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedU.S. Chargebacks & Rebates Accrual — Current-Year Sales Provision ($M) ($M)Year on yearSource
FY2025Dec 31, 202510,219-24.0%Form 10-K (mrk-20251231.htm, filed 2026-02-24) ↗
FY2024Dec 31, 202413,450+7.3%Form 10-K (mrk-20251231.htm, filed 2026-02-24) ↗
FY2023Dec 31, 202312,540+1.1%Form 10-K (mrk-20241231.htm, filed 2025-02-25) ↗
FY2022Dec 31, 202212,4080.0%Form 10-K (mrk-20231231.htm, filed 2024-02-26) ↗
FY2021Dec 31, 202112,412+8.7%Form 10-K (mrk-20221231.htm, filed 2023-02-24) ↗
FY2020Dec 31, 202011,423-4.8%Form 10-K (mrk-20211231.htm, filed 2022-02-25) ↗
FY2019Dec 31, 201911,999+10.7%Form 10-K (mrk-20201231.htm, filed 2021-02-25) ↗
FY2018Dec 31, 201810,837-1.5%Form 10-K (mrk1231201910k.htm, filed 2020-02-26) ↗
FY2017Dec 31, 201711,001+11.9%Form 10-K (mrk1231201810k.htm, filed 2019-02-27) ↗
FY2016Dec 31, 20169,831–Form 10-K (mrk1231201710k.htm, filed 2018-02-27) ↗

Cite this data

StockData. (2026). Merck U.S. Chargebacks & Rebates Accrual — Current-Year Sales Provision ($M) ($M), annual FY2016–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/gtn_us_roll_prov

See every metric in the Merck KPI table. Data updated Oct 26, 2026.